ABRAXAS1 and cancer: Seven genes (BORA, DIS3, POLR2C, FAM175A, EME1, RNF139 and SHMT1) are considered potential biomarkers and/or potential targets for radiotherapy and chemotherapy, as well as cancer susceptibility, cancer progression and metastasis-related genes (Supplementary file 2: Table S7).